81: Encounter for therapeutic drug level monitoring.
1X5A: Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter.
ICD-10-CM Code for Unspecified adverse effect of drug or medicament T88. 7.
ICD-10 Codes for Long-term TherapiesCodeLong-term (current) use ofZ79.84oral hypoglycemic drugsZ79.891opiate analgesicZ79.899other drug therapy21 more rows•Aug 15, 2017
Breast Cancer ICD-10 Code Reference SheetFEMALERightC50.811Malignant neoplasm of overlapping sites, right female breastC50.911Malignant neoplasm of unspecified site, right female breastD05.01Lobular carcinoma in situ, right breast9 more rows
Antineoplastic drugs are medications used to treat cancer. Antineoplastic drugs are also called anticancer, chemotherapy, chemo, cytotoxic, or hazardous drugs. These drugs come in many forms.
ICD-10-PCS GZ3ZZZZ is a specific/billable code that can be used to indicate a procedure.
Toxic effects should be sequenced first, followed by code(s) for all manifestations. When no intent is indicated, you should code as accidental. Undetermined intent is only for use when there is specific documentation in the record that the intent of the toxic effect cannot be determined.Mar 27, 2018
ICD-10 code Z79. 899 for Other long term (current) drug therapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
E78.5ICD-10 | Hyperlipidemia, unspecified (E78. 5)
899 or Z79. 891 depending on the patient's medication regimen. That said, it was always a supporting diagnosis, never primary. It might be okay for primary for drug testing or something of the sort.Mar 7, 2019
ICD 10 codes for diuretics and ICD Code Y54. 5.
Z79.02 Long term (current) use of antithrombotics/an... Z79.1 Long term (current) use of non-steroidal anti... Z79.2 Long term (current) use of antibiotics. Z79.3 Long term (current) use of hormonal contracep... Z79.4 Long term (current) use of insulin.
Categories Z40-Z53 are intended for use to indicate a reason for care. They may be used for patients who have already been treated for a disease or injury, but who are receiving aftercare or prophylactic care, or care to consolidate the treatment, or to deal with a residual state. Type 2 Excludes.